Do we still need breast cancer screening in the era of targeted therapies and precision medicine?

Do we still need breast cancer screening in the era of targeted therapies and precision medicine?

Abstract Breast cancer (BC) is the most common female cancer and the second cause of death among women worldwide. The 5-year relative survival rate recently improved up to 90% due to increased population coverage and women’s attendance to organised mammography screening as well as to advances in the...

Full description

Bibliographic Details
Main Authors: Rubina Manuela Trimboli, Paolo Giorgi Rossi, Nicolò Matteo Luca Battisti, Andrea Cozzi, Veronica Magni, Moreno Zanardo, Francesco Sardanelli
Format: Article
Language:English
Published: SpringerOpen 2020-09-01
Series:Insights into Imaging
Subjects:
Breast neoplasms
Mammography
Cancer screening
Prognosis
Precision medicine
Online Access:http://link.springer.com/article/10.1186/s13244-020-00905-3

Internet

http://link.springer.com/article/10.1186/s13244-020-00905-3

Similar Items